Literature DB >> 1584563

Intravitreal penetration of oral ciprofloxacin in humans.

F Z el Baba1, M D Trousdale, W J Gauderman, D G Wagner, P E Liggett.   

Abstract

Nineteen patients about to undergo elective vitreous surgery received 1 oral dose of 750 mg of ciprofloxacin before surgery. Specimens of serum and vitreous were collected 90 minutes to 18 hours after drug administration and were assayed for antibiotic content with a microbiologic disk agar technique. From 4 hours and 50 minutes to 16 hours and 50 minutes after a single oral dose, ciprofloxacin reached intravitreal levels above its minimal inhibitory concentration for 90% of Staphylococcus epidermidis, Bacillus species, and Enterobacteriaceae. However, intravitreal levels never exceeded the MIC90 for Staphylococcus aureus and Pseudomonas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1584563     DOI: 10.1016/s0161-6420(92)31943-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  17 in total

1.  Penetration of levofloxacin into the anterior chamber (aqueous humour) of the human eye after intravenous administration.

Authors:  E García-Vázquez; J Mensa; M Sarasa; Y López; P D Couchard; D Soy; J R Fontenla
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

2.  Penetration of gentamicin and ofloxacin in human vitreous after systemic administration.

Authors:  H Verbraeken; A Verstraete; E Van de Velde; G Verschraegen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

3.  Vitreous penetration of levofloxacin in the uninflamed phakic human eye.

Authors:  E N Herbert; I A Pearce; J McGalliard; D Wong; C Groenewald
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

Review 4.  Infectious endophthalmitis after cataract surgery.

Authors:  D S Hughes; R J Hill
Journal:  Br J Ophthalmol       Date:  1994-03       Impact factor: 4.638

Review 5.  Fluoroquinolones: place in ocular therapy.

Authors:  A Smith; P M Pennefather; S B Kaye; C A Hart
Journal:  Drugs       Date:  2001       Impact factor: 9.546

6.  Pharmacokinetics of ciprofloxacin in the human eye: a clinical study and population pharmacokinetic analysis.

Authors:  N Morlet; G G Graham; B Gatus; A J McLachlan; C Salonikas; D Naidoo; I Goldberg; C M Lam
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

7.  Subretinal fluid levels of topical, oral, and combined administered ciprofloxacin in humans.

Authors:  O Cekiç; C Batman; U Yaşar; N E Başci; O Zilelioğlu; A Bozkurt
Journal:  Br J Ophthalmol       Date:  2000-09       Impact factor: 4.638

8.  Antimicrobial pharmacokinetics in endophthalmitis treatment: studies of ceftazidime.

Authors:  T A Meredith
Journal:  Trans Am Ophthalmol Soc       Date:  1993

Review 9.  Endophthalmitis after lens extraction.

Authors:  H E Verbraeken
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

10.  Intravenous treatment of experimental Staphylococcus aureus endophthalmitis: imipenem versus the combination of ceftazidime and amikacin.

Authors:  Michael Engelbert; Herminia Miño de Kaspar; Martina Mette; Martin Thiel; Christopher N Ta; Thomas Grasbon; Markus Schulze-Schwering; Volker Klauss; Anselm Kampik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-14       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.